N-omega-nitro-L-arginine methyl ester Recruiting Phase 1 Trials for Cardiovascular Risk Factors / Vasoconstriction / Cardiovascular Disease (CVD) Basic Science

IndicationsStatusPurposePhase
RecruitingBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT03684213Local Antioxidant Therapy Vasoconstriction Effects in Different Races
NCT03679780The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction